|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
The National Board of Health and Welfare:
Cancer incidence in Sweden 2008. The National Board of Health and
Welfare. Stockholm: 2009.
|
|
3
|
National Quality Register for Cervical
Screening: Prevention of cervical cancer in Sweden. Annual report
2014 with data to 2013. National Quality Register for Cervical
Screening. (Stockholm, Swedish). 2014.
|
|
4
|
Bosch FX and Muñoz N: The viral etiology
of cervical cancer. Virus Res. 89:183–190. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Woodman CB, Collins SI and Young LS: The
natural history of cervical HPV infection: Unresolved issues. Nat
Rev Cancer. 7:11–22. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Münger K: Disruption of oncogene/tumor
suppressor networks during human carcinogenesis. Cancer Invest.
20:71–81. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pett M and Coleman N: Integration of
high-risk human papillomavirus: A key event in cervical
carcinogenesis? J Pathol. 212:356–367. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Imaoka H, Toiyama Y, Okigami M, Yasuda H,
Saigusa S, Ohi M, Tanaka K, Inoue Y, Mohri Y and Kusunoki M:
Circulating microRNA-203 predicts metastases, early recurrence and
poor prognosis in human gastric cancer. Gastric Cancer. 19:744–753.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Naucler P, Ryd W, Törnberg S, Strand A,
Wadell G, Elfgren K, Rådberg T, Strander B, Johansson B, Forslund
O, et al: Human papillomavirus and Papanicolaou tests to screen for
cervical cancer. N Engl J Med. 357:1589–1597. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Giorgi-Rossi P, Franceschi S and Ronco G:
HPV prevalence and accuracy of HPV testing to detect high-grade
cervical intraepithelial neoplasia. Int J Cancer. 130:1387–1394.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bergström R, Sparén P and Adami HO: Trends
in cancer of the cervix uteri in Sweden following cytological
screening. Br J Cancer. 81:159–166. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cuzick J, Clavel C, Petry KU, Meijer CJ,
Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni
P and Iftner T: Overview of the European and North American studies
on HPV testing in primary cervical cancer screening. Int J Cancer.
119:1095–1101. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nanda K, McCrory DC, Myers ER, Bastian LA,
Hasselblad V, Hickey JD and Matchar DB: Accuracy of the
Papanicolaou test in screening for and follow-up of cervical
cytologic abnormalities: A systematic review. Ann Intern Med.
132:810–819. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Strander B, Andersson-Ellström A, Milsom
I, Rådberg T and Ryd W: Liquid-based cytology versus conventional
Papanicolaou smear in an organized screening program: A prospective
randomized study. Cancer. 111:285–291. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Persson M, Elfström KM, Brismar Wendel S,
Weiderpass E and Andersson S: Triage of HR-HPV positive women with
minor cytological abnormalities: A comparison of mRNA testing, HPV
DNA testing and repeat cytology using a 4-year follow-up of a
population-based study. PLoS One. 9:e900232014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lui WO, Pourmand N, Patterson BK and Fire
A: Patterns of known and novel small RNAs in human cervical cancer.
Cancer Res. 67:6031–6043. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang X, Tang S, Le SY, Lu R, Rader JS,
Meyers C and Zheng ZM: Aberrant expression of oncogenic and
tumor-suppressive microRNAs in cervical cancer is required for
cancer cell growth. PLoS One. 3:e25572008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Witten D, Tibshirani R, Gu SG, Fire A and
Lui WO: Ultra-high throughput sequencing-based small RNA discovery
and discrete statistical biomarker analysis in a collection of
cervical tumours and matched controls. BMC Biol. 8:582010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie H, Zhao Y, Caramuta S, Larsson C and
Lui WO: MiR-205 expression promotes cell proliferation and
migration of human cervical cancer cells. PLoS One. 7:e469902012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hagrass HA, Sharaf S, Pasha HF, Tantawy
EA, Mohamed RH and Kassem R: Circulating microRNAs-a new horizon in
molecular diagnosis of breast cancer. Genes Cancer. 6:281–287.
2015.PubMed/NCBI
|
|
22
|
He Y, Lin J, Kong D, Huang M, Xu C, Kim
TK, Etheridge A, Luo Y, Ding Y and Wang K: Current state of
circulating microRNAs as cancer biomarkers. Clin Chem.
61:1138–1155. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin XJ, Chong Y, Guo ZW, Xie C, Yang XJ,
Zhang Q, Li SP, Xiong Y, Yuan Y, Min J, et al: A serum microRNA
classifier for early detection of hepatocellular carcinoma: A
multicentre, retrospective, longitudinal biomarker identification
study with a nested case-control study. Lancet Oncol. 16:804–815.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mu YP, Sun WJ, Lu CW and Su XL: MicroRNAs
may serve as emerging molecular biomarkers for diagnosis and
prognostic assessment or as targets for therapy in gastric cancer.
Asian Pac J Cancer Prev. 16:4813–4820. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nonaka R, Miyake Y, Hata T, Kagawa Y, Kato
T, Osawa H, Nishimura J, Ikenaga M, Murata K, Uemura M, et al:
Circulating miR-103 and miR-720 as novel serum biomarkers for
patients with colorectal cancer. Int J Oncol. 47:1097–1102.
2015.PubMed/NCBI
|
|
26
|
Yu J, Jin L, Jiang L, Gao L, Zhou J, Hu Y,
Li W, Zhi Q and Zhu X: Serum miR-372 is a diagnostic and prognostic
biomarker in patients with early colorectal cancer. Anticancer
Agents Med Chem. 16:424–431. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Orang AV, Safaralizadeh R, Hosseinpour
Feizi MA and Somi MH: Diagnostic and prognostic value of miR-205 in
colorectal cancer. Asian Pac J Cancer Prev. 15:4033–4037. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zheng H, Zhang L, Zhao Y, Yang D, Song F,
Wen Y, Hao Q, Hu Z, Zhang W and Chen K: Plasma miRNAs as diagnostic
and prognostic biomarkers for ovarian cancer. PLoS One.
8:e778532013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yue X, Lan F, Hu M, Pan Q, Wang Q and Wang
J: Downregulation of serum microRNA-205 as a potential diagnostic
and prognostic biomarker for human glioma. J Neurosurg.
124:122–128. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ma Q, Wan G, Wang S, Yang W, Zhang J and
Yao X: Serum microRNA-205 as a novel biomarker for cervical cancer
patients. Cancer Cell Int. 14:812014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao S, Yao D, Chen J and Ding N:
Circulating miRNA-20a and miRNA-203 for screening lymph node
metastasis in early stage cervical cancer. Genet Test Mol
Biomarkers. 17:631–636. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Malta M, Ribeiro J, Monteiro P, Loureiro
J, Medeiros R and Sousa H: Let-7c is a candidate biomarker for
cervical intraepithelial lesions: A pilot study. Mol Diagn Ther.
19:191–196. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tian Q, Li Y, Wang F, Li Y, Xu J, Shen Y,
Ye F, Wang X, Cheng X, Chen Y, et al: MicroRNA detection in
cervical exfoliated cells as a triage for human
papillomavirus-positive women. J Natl Cancer Inst. 106:pii: dju241.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fröberg M, Johansson B, Hjerpe A and
Andersson S: Human papillomavirus ‘reflex’ testing as a screening
method in cases of minor cytological abnormalities. Br J Cancer.
99:563–568. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Solomon D, Davey D, Kurman R, Moriarty A,
O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, et
al: The 2001 bethesda system: Terminology for reporting results of
cervical cytology. JAMA. 287:2114–2119. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Canavan TP and Doshi NR: Cervical cancer.
Am Fam Physician. 61:1369–1376. 2000.PubMed/NCBI
|
|
38
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Qin AY, Zhang XW, Liu L, Yu JP, Li H, Wang
SZ, Ren XB and Cao S: MiR-205 in cancer: An angel or a devil? Eur J
Cell Biol. 92:54–60. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Martinez I, Gardiner AS, Board KF, Monzon
FA, Edwards RP and Khan SA: Human papillomavirus type 16 reduces
the expression of microRNA-218 in cervical carcinoma cells.
Oncogene. 27:2575–2582. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang X, Wang HK, Li Y, Hafner M, Banerjee
NS, Tang S, Briskin D, Meyers C, Chow LT, Xie X, et al: MicroRNAs
are biomarkers of oncogenic human papillomavirus infections. Proc
Natl Acad Sci USA. 111:4262–4267. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nielsen BS: MicroRNA in situ
hybridization. Methods Mol Biol. 822:67–84. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ge J, Zhang LL, Liu SJ, Yu RQ and Chu X: A
highly sensitive target-primed rolling circle amplification (TPRCA)
method for fluorescent in situ hybridization detection of microRNA
in tumor cells. Anal Chem. 86:1808–1815. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wu M, Piccini M, Koh CY, Lam KS and Singh
AK: Single cell microRNA analysis using microfluidic flow
cytometry. PLoS One. 8:e550442013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wu M, Piccini ME and Singh AK: MiRNA
detection at single-cell resolution using microfluidic LNA
flow-FISH. Methods Mol Biol. 1211:245–260. 2014. View Article : Google Scholar : PubMed/NCBI
|
